BioCentury
ARTICLE | Company News

Rigel and Novartis begin third discovery collaboration

August 24, 2000 7:00 AM UTC

Rigel (South San Francisco, Calif.) will use its combinatorial biology technology to identify small molecule targets to regulate lung epithelial cell function to treat diseases such as asthma and chro...